PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
AboutPricing
Disease Reportsherpes simplex encephalitis
MeSH D020803 - herpes simplex encephalitis
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
D018792:Viral encephalitis
0 Companies
0 Drugs
Success rate
D006566:Herpesviridae infections
$
Success rate
D020803: 
Herpes simplex encephalitis
$
Success rate
Events Timeline
Loading
Commercial
Company Name
Drug Name
Trade Name
Patent Expires
Approval Date
Revenue
Period
TevaAcyclovir Acyclovir  1997-04-22   
PadagisAcyclovir Acyclovir  2019-02-20   
Taro PharmaceuticalAcyclovir Acyclovir  2016-12-21   
Glenmark PharmaceuticalsAcyclovir Acyclovir  2017-07-31   
MylanAcyclovir Acyclovir  1998-04-13   
Acyclovir Zovirax  1985-01-25   
XiromedAcyclovir Acyclovir  2020-01-29   
GSKAcyclovir Zovirax  1982-10-22   
CiplaAcyclovir Acyclovir  2019-01-18   
AbbVieAcyclovir Acyclovir  1999-07-26   
Bausch Health CompaniesHydrocortisone, Acyclovir Xerese  2009-07-31   
Acyclovir Zovirax  1982-03-29   
1
2
3
4
5
>
Clinical Trials
Historical Success Rate
Phase 1
0%
0/0
Phase 2
0%
0/0
Phase 3
100%
1/1
Approved: 1Overall Success rate: 0%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name
Phase 1
Phase 2
Phase 3
Phase 4
Drug Name
Padagis
1
2
3
4
>
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use